American Well Corporation
General ticker "AMWL" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $120.7M (TTM average)
American Well Corporation does not follow the US Stock Market performance with the rate: -5.3%.
Estimated limits based on current volatility of 2.3%: low 4.03$, high 4.22$
Factors to consider:
- Total employees count: 877 as of 2024
- Top business risk factors: History of losses, Customer concentration, Pandemic risks, Management dependency, Data center disruptions
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.16$, 13.83$]
- 2025-12-31 to 2026-12-31 estimated range: [3.93$, 12.84$]
Financial Metrics affecting the AMWL estimates:
- Negative: with PPE of -0.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -110.95 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 69.91 > 63.39
- Negative: Investing cash flow per share per price, % of -16.25 <= -14.38
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term AMWL quotes
Long-term AMWL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $277.19MM | $259.05MM | $254.36MM |
| Operating Expenses | $553.04MM | $951.19MM | $471.90MM |
| Operating Income | $-275.85MM | $-692.14MM | $-217.53MM |
| Non-Operating Income | $6.12MM | $19.42MM | $10.76MM |
| R&D Expense | $138.49MM | $105.83MM | $86.06MM |
| Income(Loss) | $-269.73MM | $-672.72MM | $-206.78MM |
| Taxes | $0.06MM | $3.86MM | $2.75MM |
| Profit(Loss)* | $-268.15MM | $-675.16MM | $-208.14MM |
| Stockholders Equity | $1,063.88MM | $464.22MM | $304.77MM |
| Inventory | $8.74MM | $6.65MM | $2.86MM |
| Assets | $1,217.56MM | $589.71MM | $435.97MM |
| Operating Cash Flow | $-192.32MM | $-148.34MM | $-127.34MM |
| Capital expenditure | $10.45MM | $15.25MM | $15.22MM |
| Investing Cash Flow | $-11.63MM | $-19.17MM | $-18.65MM |
| Financing Cash Flow | $-3.61MM | $2.15MM | $1.38MM |
| Earnings Per Share** | $-19.56 | $-47.50 | $-13.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.